The purpose of Fellow status is to recognize and honor outstanding contributions to the science and practice of psychosocial oncology. Membership in the Fellowship is not purely honorific, however: it carries an expectation of ongoing contributions to and leadership within the Society. View the APOS Fellow eligibility criteria.
VICKI KENNEDY, LCSW
Vicki Kennedy is the Executive Director of Oncology Strategy and Patient Engagement for Cullari Communications Global. Ms. Kennedy is leading expert in psychosocial oncology including screening and management of cancer-related distress, treatment decision support, and effective integration of patient engagement strategies that help define patient value, improve quality of life and enhance health outcomes. Prior to coming to CCG, Vicki served as Vice President of Program Development & Delivery for the Cancer Support Community (CSC) in Washington, DC, where she was responsible for development, delivery and quality assurance of CSC clinical programs worldwide.
An oncology social worker for the past 35 years, Ms. Kennedy has dedicated her career to ensuring that people touched by cancer have awareness of and access to evidence-based psychosocial care. Vicki is a past-president of Association of Oncology Social Work and currently serves on the board of the American Psychosocial Oncology Society. She also serves on the Editorial Board for the Journal of Oncology Practice Management. A leading speaker for patient advocacy, engagement and survivorship, Ms. Kennedy was awarded the Association of Oncology Social Work’s Quality of Life in Cancer Care Award highlighting oncology social work’s commitment to improving the lives of people with cancer.
DONALD L. ROSENSTEIN, MD
Dr. Rosenstein is Professor of Psychiatry and Medicine at the University of North Carolina where he is Director of the Comprehensive Cancer Support Program and Vice-Chair of the Division of Hospital Psychiatry. Dr. Rosenstein earned his undergraduate degree in psychology from Wesleyan University, his medical degree from Northwestern University School of Medicine, and completed his residency training in psychiatry at Yale University. He is the former Clinical Director of the National Institute of Mental Health (NIMH) and Past-President of both the Academy of Consultation Liaison Psychiatry and the American Psychosocial Oncology Society (APOS). Dr. Rosenstein and Justin Yopp, PhD are the authors of The Group: Seven Widowed Fathers Reimagine Life (Oxford University Press).
JOSEPH GREER, PHD
Dr. Joseph Greer is the Program Director of the Center for Psychiatric Oncology & Behavioral Sciences and the Associate Director of the Cancer Outcomes Research Program at the Massachusetts General Hospital Cancer Center. He is also an Assistant Professor of Psychology at Harvard Medical School.
Dr. Greer’s research focuses on the development and testing of supportive care interventions for patients with cancer. As the principal investigator and collaborator on numerous grant-funded projects, he is studying the application of cognitive-behavioral therapy (CBT) to treat anxiety in patients with advanced cancer; nurse-delivered behavioral interventions to improve breathlessness in patients with lung cancer; the use of mobile technology to promote symptom management and adherence to oral chemotherapy medications; and the benefits of early palliative care integrated with standard oncology care. Dr. Greer has published over 85 scholarly papers, reviews, chapters, and commentaries related to this work. He has received funding from the National Institutes of Health, American Cancer Society, Patient Centered Outcomes Research Institute, and philanthropic donations. Dr. Greer’s program of research is greatly informed by his clinical practice at the MGH Cancer Center where he provides CBT for patients and their families.
ISABEL SCHUERMEYER, MD
Dr. Schuermeyer is a psychiatrist who is board certified in Consultation-Liaison psychiatry (previously psychosomatic medicine) and has worked at the Cleveland Clinic since completing fellowship in 2005. While in fellowship she started working in the field of Psychosocial Oncology and helped develop the Interdisciplinary Psychosocial Oncology team at the Taussig Cancer Center.
Dr. Schuermeyer is a clinician who treats patients with cancer along with either new onset psychiatric symptoms or exacerbation of an underlying psychiatric illness. Her focus has been on a team-based approach, including the oncology team, given the risk of interactions between psychiatric medicines and cancer treatments. Her research interests are end of life decisions, determining capacity and working within an interdisciplinary team. She is a past-president of American Psychosocial Oncology Society and has been involved with the American Psychiatric Association.
Dr. Schuermeyer is active in teaching psychiatry residents and fellows, as well as palliative medicine fellows. When not at work, she is busy being a soccer mom, talking her husband out of buying a truck to haul more beehives, making soap, and attempting to keep her kids out of trouble.
At the 2012 APOS 9th Annual Conference, the APOS Board of Directors decided to explore establishing a Fellow status for the organization. A task force was formed in April 2012, and that task force presented a proposal to the Board in August recommending creation of this honorary status, as well as suggesting eligibility criteria and selection procedures.
At the 2013 APOS 10th Annual Conference, the APOS Board presented the first class of APOS fellows, individuals recognized for their outstanding contributions to the science and practice of psychosocial oncology. In honor of the 10th anniversary of the organization, 10 fellows were inducted.